Gene Veritas (aka Kenneth P. Serbin) reports on the clinical trial for a gene-silencing Huntington's disease treatment in the final planning stages at Isis Pharmaceuticals, Inc., and Roche. He interviewed members of the Isis Huntington's team on August 22, 2014.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…